444 related articles for article (PubMed ID: 24854193)
41. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
[TBL] [Abstract][Full Text] [Related]
42. Identification of a novel CSF3R-SPTAN1 fusion gene in an atypical chronic myeloid leukemia patient with t(1;9)(p34;q34) by RNA-Seq.
Sheng G; Zhang J; Zeng Z; Pan J; Wang Q; Wen L; Xu Y; Wu D; Chen S
Cancer Genet; 2017 Oct; 216-217():16-19. PubMed ID: 29025591
[TBL] [Abstract][Full Text] [Related]
43. De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML.
Bartels S; Lehmann U; Büsche G; Schlue J; Hussein K; Debatin D; Karcher A; Andrulis M; Schirmacher P; Kreipe H
Ann Hematol; 2015 Jul; 94(7):1255-6. PubMed ID: 25865944
[No Abstract] [Full Text] [Related]
44. Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.
Shou LH; Cao D; Dong XH; Fang Q; Wu Y; Zhang Y; Fei JP; Xu BL
PLoS One; 2017; 12(2):e0171608. PubMed ID: 28158286
[TBL] [Abstract][Full Text] [Related]
45. Current strategies in the diagnosis and management of chronic neutrophilic leukemia.
Otgonbat A; Zhao M
Chin Med J (Engl); 2014; 127(24):4258-62. PubMed ID: 25533830
[TBL] [Abstract][Full Text] [Related]
46. [The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia].
Cui YJ; Jiang Q; Liu JQ; Li B; Xu ZF; Qin TJ; Zhang Y; Cai WY; Zhang HL; Fang LW; Pan LJ; Hu NB; Qu SQ; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):28-32. PubMed ID: 28219221
[No Abstract] [Full Text] [Related]
47. Chronic neutrophilic leukemia complicated with monoclonal gammopathy of undetermined significance: A case report and literature review.
Gao JP; Zhai LJ; Gao XH; Min FL
J Clin Lab Anal; 2022 Apr; 36(4):e24287. PubMed ID: 35170077
[TBL] [Abstract][Full Text] [Related]
48. Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.
Li B; Gale RP; Xiao Z
J Hematol Oncol; 2014 Dec; 7():93. PubMed ID: 25498990
[TBL] [Abstract][Full Text] [Related]
49. Changes in allele frequencies of
Nooruddin Z; Miltgen N; Wei Q; Schowinsky J; Pan Z; Tobin J; Purev E; Gutman JA; Robinson W; Pollyea DA
Haematologica; 2017 May; 102(5):e207-e209. PubMed ID: 28209656
[No Abstract] [Full Text] [Related]
50. An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T.
Talati C; Padron E
Curr Hematol Malig Rep; 2016 Dec; 11(6):425-433. PubMed ID: 27664113
[TBL] [Abstract][Full Text] [Related]
51. Atypical Chronic Myeloid Leukemia: Where Are We Now?
Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
[TBL] [Abstract][Full Text] [Related]
52. The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy.
Elliott MA; Tefferi A
Curr Opin Hematol; 2014 Mar; 21(2):148-54. PubMed ID: 24335708
[TBL] [Abstract][Full Text] [Related]
53. Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
Jian J; Qiao Y; Li Y; Guo Y; Ma H; Liu B
Clin Transl Oncol; 2021 Sep; 23(9):1731-1742. PubMed ID: 33861431
[TBL] [Abstract][Full Text] [Related]
54. Genetically informed therapy in leukemia.
Radich J
N Engl J Med; 2013 May; 368(19):1838-9. PubMed ID: 23656651
[No Abstract] [Full Text] [Related]
55. Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization.
Castelli R; Cugno M; Gianelli U; Pancrazzi A; Vannucchi AM
Pathol Res Pract; 2015 Apr; 211(4):341-3. PubMed ID: 25480691
[TBL] [Abstract][Full Text] [Related]
56. Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.
Ammatuna E; Eefting M; van Lom K; Kavelaars FG; Valk PJ; Touw IP
Ann Hematol; 2015 May; 94(5):879-80. PubMed ID: 25491280
[No Abstract] [Full Text] [Related]
57.
Linder K; Iragavarapu C; Liu D
Biomark Res; 2017; 5():33. PubMed ID: 29225884
[TBL] [Abstract][Full Text] [Related]
58. CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co-contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis, severe infections, persistent fever and deep venous thrombosis.
Luo Q; Shen J; Yang Y; Tang H; Shi M; Liu J; Liu Z; Shi X; Yi Y
Br J Haematol; 2018 Mar; 180(6):892-894. PubMed ID: 27984641
[No Abstract] [Full Text] [Related]
59. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
Patnaik MM; Tefferi A
Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682
[TBL] [Abstract][Full Text] [Related]
60. CALR mutation studies in chronic neutrophilic leukemia.
Lasho TL; Elliott MA; Pardanani A; Tefferi A
Am J Hematol; 2014 Apr; 89(4):450. PubMed ID: 24421250
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]